B. Tran

CD25+ Immunoregulatory CD4 T Cells Mediate Acquired Central Transplantation Tolerance1

J. Markmann, M. K. Lee, A. Caton, 2003, The Journal of Immunology.

Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA

R. Kornbluth, G. Stone, B. Tran, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial

Kenneth E. Homer, R. Loomba, J. Neutel, 2019, Journal of Hepatology.

A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia

D. Koeberl, S. Refetoff, P. Yen, 2019 .

A liver-specific thyromimetic, VK2809, decreases hepatosteatosis in glycogen storage disease type Ia (GSD Ia).

D. Koeberl, S. Refetoff, P. Yen, 2019, Thyroid : official journal of the American Thyroid Association.

Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma

Daniel G. Anderson, R. Langer, R. Kornbluth, 2009, PloS one.

The discovery and development of binimetinib for the treatment of melanoma

Mark S. Cohen, B. Tran, 2020, Expert opinion on drug discovery.

PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis

G. Narla, M. Kester, T. Bender, 2023, The Journal of clinical investigation.